Authors:
HENNESSY A
GILLIN AG
THOMPSON JF
PAINTER DM
WAUGH RD
DUGGIN GG
TILLER DJ
HORVATH JS
Citation: A. Hennessy et al., ENDOTHELIN IN PRIMATE PREGNANCY AND AN EXPERIMENTAL PREECLAMPSIA-LIKESYNDROME, Hypertension in pregnancy, 17(3), 1998, pp. 227-240
Authors:
FAXEN M
NASIELL J
LUNELL NO
NISELL H
BLANCK A
Citation: M. Faxen et al., ALTERED PLACENTAL MESSENGER-RNA EXPRESSION OF THE PROGESTERONE BUT NOT THE ESTROGEN-RECEPTOR IN PREGNANCIES COMPLICATED BY PREECLAMPSIA, Hypertension in pregnancy, 17(3), 1998, pp. 241-249
Citation: R. Hjertberg et al., BLOOD-PRESSURE MONITORING IN WOMEN WITH PREVIOUS DIAGNOSIS OF PREECLAMPSIA - THE INFLUENCE OF THE MENSTRUAL-CYCLE, Hypertension in pregnancy, 17(3), 1998, pp. 251-263
Authors:
SCHORR SJ
SULLIVAN CA
CALFEE EF
BLAKE PG
PICKETT RA
MARTIN JN
Citation: Sj. Schorr et al., WOUND COMPLICATIONS FOLLOWING CESAREAN DELIVERY OF PATIENTS WITH HELLP-SYNDROME - PFANNENSTIEL VERSUS VERTICAL SKIN INCISION, Hypertension in pregnancy, 17(3), 1998, pp. 265-270
Authors:
KUBLICKIENE KR
GRUNEWALD C
LINDBLOM B
NISELL H
Citation: Kr. Kublickiene et al., MYOGENIC AND ENDOTHELIAL PROPERTIES OF MYOMETRIAL RESISTANCE ARTERIESFROM WOMEN WITH PREECLAMPSIA, Hypertension in pregnancy, 17(3), 1998, pp. 271-281
Authors:
BROCKELSBY JC
WHEELER T
ANTHONY FW
WELLINGS R
BAKER PN
Citation: Jc. Brockelsby et al., INCREASED CIRCULATING LEVELS OF VASCULAR ENDOTHELIAL GROWTH-FACTOR INPREECLAMPSIA, Hypertension in pregnancy, 17(3), 1998, pp. 283-290
Citation: Hm. Laivuori et al., LACK OF PREVIOUS EXPOSURE TO PATERNAL ANTIGENS DOES NOT PREDISPOSE TOHYPERTENSIVE PREGNANCY COMPLICATIONS, Hypertension in pregnancy, 17(3), 1998, pp. 291-295
Authors:
OHSHIGE A
YOSHIMURA T
MATSUI K
KOYAMA H
ITO M
OKAMURA H
Citation: A. Ohshige et al., REDUCED PLATELET-ACTIVATING FACTOR-ACETYLHYDROLASE ACTIVITY IN MATERNAL PLASMA OBTAINED FROM NORMOTENSIVE PREGNANT-WOMEN DESTINED DEVELOP PREGNANCY-INDUCED HYPERTENSION, Hypertension in pregnancy, 17(3), 1998, pp. 297-306
Authors:
RANTA VH
ORPANA AK
MIKKOLA TS
VIINIKKA LU
YLIKORKALA RO
Citation: Vh. Ranta et al., PREECLAMPSIA AND EXPRESSION OF INDUCIBLE NITRIC-OXIDE SYNTHASE MESSENGER-RNA IN UMBILICAL VEIN ENDOTHELIAL-CELLS, Hypertension in pregnancy, 17(3), 1998, pp. 307-314
Citation: J. Bar et al., LOW SERUM PLACENTAL ISOFERRITIN IN PREGNANT-WOMEN AT RISK OF DEVELOPING PREECLAMPSIA, Hypertension in pregnancy, 17(3), 1998, pp. 315-321
Authors:
BELLART J
GILABERT R
FONTCUBERTA J
BORRELL M
MIRALLES RM
CABERO L
Citation: J. Bellart et al., COAGULATION AND FIBRINOLYSIS PARAMETERS IN NORMAL AND IN HYPERTENSIVEPREGNANCIES, Hypertension in pregnancy, 17(2), 1998, pp. 115-123
Citation: Sm. Khedun et al., PLASMA AND RED-CELL MAGNESIUM LEVELS IN BLACK-AFRICAN WOMEN WITH HYPERTENSIVE DISORDERS OF PREGNANCY, Hypertension in pregnancy, 17(2), 1998, pp. 125-134
Citation: Am. Pouta et al., THE ASSOCIATION OF PLASMA ENDOTHELIN WITH CLINICAL-PARAMETERS IN PREECLAMPSIA, Hypertension in pregnancy, 17(2), 1998, pp. 135-145
Authors:
NISELL H
GRUNEWALD C
BERGLUND M
KARLBERG KE
LUNELL NO
SYLVEN C
Citation: H. Nisell et al., PLATELET-AGGREGATION IN-VITRO AND EX-VIVO IN NORMAL-PREGNANCY, PREGNANCY-INDUCED HYPERTENSION, AND PREECLAMPSIA, Hypertension in pregnancy, 17(2), 1998, pp. 147-155
Citation: Tn. Leung et al., CHANGES IN CONCENTRATIONS OF LIPOPROTEIN (A) AND OTHER LIPIDS AND LIPOPROTEINS IN PREGNANCIES COMPLICATED BY PREGNANCY-INDUCED HYPERTENSIONOR INTRAUTERINE GROWTH-RETARDATION, Hypertension in pregnancy, 17(2), 1998, pp. 157-168
Authors:
KISTERS K
KORNER J
LOUWEN F
WITTELER R
SPIEKER C
ZIDEK W
BARENBROCK M
RAHN KH
Citation: K. Kisters et al., PLASMA, INTRACELLULAR, AND MEMBRANE MG2-PREGNANCY AND IN PREECLAMPSIA( CONCENTRATIONS IN NORMAL), Hypertension in pregnancy, 17(2), 1998, pp. 169-178
Authors:
CARUSO A
CAFORIO L
FERRAZZANI S
CIAMPELLI M
TESTA AC
PARADISI G
LANZONE A
Citation: A. Caruso et al., INSULIN SECRETORY PATTERNS AND UTEROPLACENTAL DOPPLER FLOW VELOCIMETRY IN PREGNANCIES COMPLICATED BY CARBOHYDRATE INTOLERANCE - IS THERE ANY RELATIONSHIP, Hypertension in pregnancy, 17(2), 1998, pp. 179-190
Citation: Ms. Rogers et B. Tomlinson, CHANGE IN CARDIOVASCULAR INDEXES WITH POSITION AND ISOMETRIC-EXERCISETHROUGHOUT PREGNANCY - ASSESSMENT BY IMPEDANCE CARDIOGRAPHY AND OSCILLOMETRIC SPHYGMOMANOMETRY, Hypertension in pregnancy, 17(2), 1998, pp. 191-202
Citation: Sw. Walsh et Yp. Wang, MATERNAL PERFUSION WITH LOW-DOSE ASPIRIN PREFERENTIALLY INHIBITS PLACENTAL THROMBOXANE WHILE SPARING PROSTACYCLIN, Hypertension in pregnancy, 17(2), 1998, pp. 203-215
Citation: S. He et al., FIBRIN D-DIMER LEVELS IN PREECLAMPTIC PREGNANCIES WITH BIRTH OF SMALL-FOR-GESTATIONAL-AGE NEONATES, Hypertension in pregnancy, 17(2), 1998, pp. 217-226
Citation: Yp. Wang et Sw. Walsh, THE RATIO OF THROMBOXANE TO PROSTACYCLIN IS INCREASED BY PEROXIDE IN A DOSE-DEPENDENT MANNER, ALONG WITH INCREASED VASOCONSTRICTION IN THE HUMAN PLACENTA, Hypertension in pregnancy, 17(1), 1998, pp. 1-11
Citation: Ma. Brown et Hl. Buddle, IS IT SAFE TO WITHHOLD CONVULSION PROPHYLAXIS IN PREECLAMPTIC WOMEN WITHOUT NEUROLOGICAL FEATURES, Hypertension in pregnancy, 17(1), 1998, pp. 13-21
Authors:
HARTIKAINEN AL
ALIHARMI RH
RANTAKALLIO PT
Citation: Al. Hartikainen et al., A COHORT STUDY OF EPIDEMIOLOGIC ASSOCIATIONS AND OUTCOMES OF PREGNANCIES WITH HYPERTENSIVE DISORDERS, Hypertension in pregnancy, 17(1), 1998, pp. 31-41
Citation: J. Moodley et M. Rajagopal, MATERNAL AND PERINATAL OUTCOME ASSOCIATED WITH HYPERTENSIVE CRISES OFPREGNANCY, Hypertension in pregnancy, 17(1), 1998, pp. 43-53